New Zealand markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
342.24+1.05 (+0.31%)
At close: 04:00PM EST
342.23 -0.01 (-0.00%)
After hours: 04:25PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 25.32B
Enterprise value 24.73B
Trailing P/E 46.12
Forward P/E 39.22
PEG ratio (5-yr expected) 5.59
Price/sales (ttm)8.83
Price/book (mrq)8.83
Enterprise value/revenue 8.45
Enterprise value/EBITDA 30.89

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 341.41%
S&P500 52-week change 314.91%
52-week high 3415.73
52-week low 3224.15
50-day moving average 3354.94
200-day moving average 3361.63

Share statistics

Avg vol (3-month) 3379.05k
Avg vol (10-day) 3368.1k
Shares outstanding 573.99M
Implied shares outstanding 673.99M
Float 873.57M
% held by insiders 10.55%
% held by institutions 194.93%
Shares short (14 Nov 2023) 41.28M
Short ratio (14 Nov 2023) 42.67
Short % of float (14 Nov 2023) 42.27%
Short % of shares outstanding (14 Nov 2023) 41.73%
Shares short (prior month 12 Oct 2023) 41.09M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.23%
Trailing annual dividend rate 30.76
Trailing annual dividend yield 30.22%
5-year average dividend yield 40.29
Payout ratio 410.24%
Dividend date 314 Nov 2023
Ex-dividend date 429 Jan 2024
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 19.11%
Operating margin (ttm)24.53%

Management effectiveness

Return on assets (ttm)13.22%
Return on equity (ttm)20.95%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)39.33
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)1.14B
Net income avi to common (ttm)559.4M
Diluted EPS (ttm)7.43
Quarterly earnings growth (yoy)33.70%

Balance sheet

Total cash (mrq)898.6M
Total cash per share (mrq)12.15
Total debt (mrq)306.8M
Total debt/equity (mrq)10.70%
Current ratio (mrq)3.70
Book value per share (mrq)38.76

Cash flow statement

Operating cash flow (ttm)768.2M
Levered free cash flow (ttm)226.02M